EP Biocomposites Share Price Today

EP Biocomposites AGM adopts FY26 results, re-appoints Rajkumar Kamat as MD

EP Biocomposites adopted FY26 audited financials and re-appointed Rajkumar Kamat as MD. Revenue rose 13.6% YoY to ₹1,363.98 lakh, with net profit up to ₹145.83 lakh. EBITDA margin expanded 174 bps to 17.43%, driven by operational leverage. Voting results show 100% approval for both resolutions via remote e-voting. Promoters voted 11,65,416 shares, while public shareholders voted 12,084 shares.

EP Biocomposites enters water body conservation partnership

EP Biocomposites signs strategic collaboration with Malligavad Foundation. Company acts as execution partner; foundation serves as technical advisor. Scope includes Goa, Konkan Division, and Karnataka coastal districts. No upfront monetary consideration paid under the agreement. Focus on water body rejuvenation and eco-restoration projects.

Ep Biocomposites wins Rs 0.92 crore work order from Beleza by the Beach

Ep Biocomposites secured a Rs 0.92 crore work order for a 70 KLD Sewage Treatment Plant from Beleza by the Beach. The order is the sole disclosure in the last three fiscal quarters, representing 100% of recent order inflow. TTM Revenue and Net Profit are reported as 0.0 Cr in the provided context, limiting immediate comparative analysis. The project has a completion deadline of April 30, 2027, with no other working capital metrics provided for assessment.

EP Biocomposites schedules AGM for Sep 28 to adopt FY26 accounts

EP Biocomposites holds its seventh AGM on September 28, 2026. Shareholders to adopt audited financials for FY26. Managing Director Rajkumar Kamat seeks re-appointment. Remote e-voting window runs from Sep 24 to Sep 27.

EP Biocomposites PAT rises 41.5% on revenue growth in FY26

EP Biocomposites Limited reported a 41.5% increase in net profit to ₹145.83 lakh for FY26, driven by a 13.6% rise in revenue to ₹1,363.98 lakh and improved operational efficiency. EBITDA grew 26.23% to ₹237.83 lakh with margins expanding to 17.44%, while net worth crossed ₹12 crore and ROCE improved to 16%. The company successfully utilized IPO proceeds for capacity expansion and debt repayment, strengthening its balance sheet with total assets rising to ₹1,873.14 lakh.

EP Biocomposites Limited Partners with IISc Bengaluru for Advanced Wastewater Treatment Solutions

EP Biocomposites Limited has signed a technical consultancy agreement with the Indian Institute of Science (IISc), Bengaluru, to strengthen its capabilities in advanced wastewater treatment solutions. The collaboration focuses on technical consultancy, design review, and expert inputs for non-biological wastewater treatment systems, enabling the company to offer unique non-biological treatment solutions for wastewater recycling. The partnership is expected to enhance process efficiency, system reliability, and regulatory compliance while supporting the company's long-term strategy of providing innovative and environmentally responsible solutions for industrial and municipal applications.